Theratechnologies

Quarterly Financials

Values in thousands 2024-11-30 2024-08-31 2024-05-31 2024-02-29
Revenue
$25,002
$22,600
$22,600
$22,010
Gross Profit
18,906
18,079
18,079
17,104
EBITDA
-3,974
6,618
6,997
4,467
EBIT
-4,467
6,213
6,508
3,205
Net Income
-7,903
3,091
3,091
987
Net Change In Cash
25,002
22,600
22,600
22,010
Free Cash Flow
-227
4,604
4,603
-1,953
Cash
5,899
34,690
34,690
31,161
Basic Shares
49,367
49,372
49,372
49,368

Annual Financials

Values in thousands 2024-11-30 2023-11-30 2022-11-30 2021-11-30
Revenue
$85,866
$81,764
$80,057
$69,823
Gross Profit
65,418
62,129
53,778
46,563
EBITDA
6,879
-10,312
-27,866
-17,156
EBIT
4,118
-13,613
-39,898
-25,735
Net Income
-8,306
-23,957
-47,237
-31,725
Net Change In Cash
85,866
81,764
80,057
69,823
Free Cash Flow
879
-7,496
-15,677
-14,643
Cash
5,899
34,097
23,856
20,399
Basic Shares
49,361
26,332
23,813
23,087

Earnings Calls

Quarter EPS
2024-11-30
-$0.22
2024-08-31
$0.06
2024-05-31
$0.02
2024-02-29
-$0.10